{"id":28707,"date":"2025-03-04T22:13:57","date_gmt":"2025-03-04T14:13:57","guid":{"rendered":"https:\/\/flcube.com\/?p=28707"},"modified":"2025-04-02T21:24:08","modified_gmt":"2025-04-02T13:24:08","slug":"organons-2024-financial-report-shows-steady-growth-in-womens-health-and-biosimilars","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=28707","title":{"rendered":"Organon&#8217;s 2024 Financial Report Shows Steady Growth in Women&#8217;s Health and Biosimilars"},"content":{"rendered":"\n<p>Women&#8217;s health specialist Organon (<a href=\"https:\/\/www.google.com\/finance\/quote\/OGN:NYSE\">NYSE: OGN<\/a>) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.<\/p>\n\n\n\n<p><strong>Global Performance<\/strong><br>Globally, Women&#8217;s Health revenues rose 5% YOY to USD 1.78 billion, primarily driven by a 17% growth in Nexplanon (etonogestrel implant) sales, which reached USD 963 million. Jada, a medical device acquired from Alydia Health for preventing abnormal postpartum uterine bleeding or hemorrhage, generated USD 61 million in sales after a 40% expansion.<\/p>\n\n\n\n<p><strong>Biosimilars Business<\/strong><br>Organon&#8217;s Biosimilars business continued to perform well, growing by 12% YOY to USD 662 million. This growth was driven by the uptake of Organon&#8217;s Humira generic Hadlima (adalimumab), which entered the US market from July 2023. Hadlima generated USD 100 million in sales in the US and USD 142 million globally in 2024. However, Organon&#8217;s Remicade biosimilar Renflexis (infliximab) and Herceptin biosimilar Ontruzant (trastuzumab) saw a 1% and 9% YOY decline to USD 274 million and USD 141 million respectively, with product maturity cited as the main cause.<\/p>\n\n\n\n<p><strong>Established Brands<\/strong><br>Established Brands maintained steady performance with USD 3.849 billion in revenues, a 2% YOY increase, with the negative impact of pricing policies partially offset by product sales.<\/p>\n\n\n\n<p><strong>Regional Performance<\/strong><br>Organon\u2019s regional performance in 2024 was as follows:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Area<\/th><th>2024 revenues (USD, mil.)<\/th><th>2023 revenues (USD, mil.)<\/th><\/tr><\/thead><tbody><tr><td>Europe and Canada<\/td><td>1,763<\/td><td>1,673<\/td><\/tr><tr><td>United States<\/td><td>1,572<\/td><td>1,478<\/td><\/tr><tr><td>Asia Pacific and Japan<\/td><td>1,050<\/td><td>1,129<\/td><\/tr><tr><td>China<\/td><td>847<\/td><td>864<\/td><\/tr><tr><td>LatAm, MiddleEast, Russia &amp; Africa<\/td><td>1,034<\/td><td>965<\/td><\/tr><tr><td>Other<\/td><td>137<\/td><td>154<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Women&#8217;s health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year&#8230;<\/p>\n","protected":false},"author":1,"featured_media":28709,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[27,972,174],"class_list":["post-28707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-finanical-reports","tag-nyse-ogn","tag-organon"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Organon&#039;s 2024 Financial Report Shows Steady Growth in Women&#039;s Health and Biosimilars - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Women&#039;s health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=28707\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon&#039;s 2024 Financial Report Shows Steady Growth in Women&#039;s Health and Biosimilars\" \/>\n<meta property=\"og:description\" content=\"Women&#039;s health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=28707\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T14:13:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-02T13:24:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Organon&#8217;s 2024 Financial Report Shows Steady Growth in Women&#8217;s Health and Biosimilars\",\"datePublished\":\"2025-03-04T14:13:57+00:00\",\"dateModified\":\"2025-04-02T13:24:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707\"},\"wordCount\":235,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0404-1-png.avif\",\"keywords\":[\"Finanical Reports\",\"NYSE: OGN\",\"Organon\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28707#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=28707\",\"name\":\"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0404-1-png.avif\",\"datePublished\":\"2025-03-04T14:13:57+00:00\",\"dateModified\":\"2025-04-02T13:24:08+00:00\",\"description\":\"Women's health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28707\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0404-1-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0404-1-png.avif\",\"width\":1080,\"height\":608,\"caption\":\"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28707#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon&#8217;s 2024 Financial Report Shows Steady Growth in Women&#8217;s Health and Biosimilars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars - Insight, China&#039;s Pharmaceutical Industry","description":"Women's health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=28707","og_locale":"en_US","og_type":"article","og_title":"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars","og_description":"Women's health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.","og_url":"https:\/\/flcube.com\/?p=28707","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-04T14:13:57+00:00","article_modified_time":"2025-04-02T13:24:08+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=28707#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=28707"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Organon&#8217;s 2024 Financial Report Shows Steady Growth in Women&#8217;s Health and Biosimilars","datePublished":"2025-03-04T14:13:57+00:00","dateModified":"2025-04-02T13:24:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=28707"},"wordCount":235,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=28707#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","keywords":["Finanical Reports","NYSE: OGN","Organon"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=28707#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=28707","url":"https:\/\/flcube.com\/?p=28707","name":"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=28707#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=28707#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","datePublished":"2025-03-04T14:13:57+00:00","dateModified":"2025-04-02T13:24:08+00:00","description":"Women's health specialist Organon (NYSE: OGN) released its 2024 financial report, showing a 3% year-on-year (YOY) increase in revenues, excluding foreign exchange effects, to USD 6.4 billion.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=28707#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=28707"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=28707#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","width":1080,"height":608,"caption":"Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=28707#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Organon&#8217;s 2024 Financial Report Shows Steady Growth in Women&#8217;s Health and Biosimilars"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0404-1-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28707"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28707\/revisions"}],"predecessor-version":[{"id":28710,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28707\/revisions\/28710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/28709"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}